Cell Point India Ltd Stock Price Today (NSE: CELLPOINT)

Cell Point India Ltd

15.352.95 (16.12%)
Market Closed

Fundamental Score

...

Cell Point India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Cell Point India Ltd share price today is 15.35, down 16.12% on NSE/BSE as of 23 June 2026. Cell Point India Ltd (CELLPOINT) is a Small-cap company in the Speciality Retail sector with a market capitalisation of 32.32 (Cr). The 52-week high for CELLPOINT share price is 21.15 and the 52-week low is 12.55. At a P/E ratio of 38.48x, CELLPOINT is currently trading below its industry average P/E of 39.01x. The company has a Return on Equity (ROE) of 0.51% and a debt-to-equity ratio of 0.90.

Cell Point India Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
18.70
Low
14.80
Volume
2.9K
Change
+7.33%

Cell Point India Ltd share price chart: 7.33% return over the past month. 52-week high ₹21.15, 52-week low ₹12.55.

Cell Point India Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
16.3016.3515.3515.354.80K (Cr)
18.7018.7018.3018.306.00K (Cr)
15.0015.3514.8015.353.60K (Cr)
16.0016.0016.0016.001.20K (Cr)
16.0016.0016.0016.001.20K (Cr)
17.0017.0017.0017.001.20K (Cr)
16.7016.7016.7016.701.20K (Cr)
18.0018.0016.8016.806.00K (Cr)
17.0517.0517.0517.052.40K (Cr)
12.9012.9012.5512.753.60K (Cr)

Cell Point India Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
16.3016.3515.3515.35-5.83%
16.7018.7014.8018.30+9.58%
12.9018.0012.5516.80+30.23%
14.1014.7513.3513.65-3.19%
16.2016.5015.3015.60-3.70%
16.3517.5015.5516.50+0.92%
17.7018.0015.8016.50-6.78%
17.7519.5017.0017.15-3.38%
18.1519.1517.3517.40-4.13%
17.9520.5017.5018.15+1.11%
18.6519.5516.4517.60-5.63%
18.1021.1517.8018.10+0.00%

AI Research Briefing

Powered by Gemini · 2026-04-10

Micro-cap lottery ticket on the Indian specialty retail boom, but fundamentals are a disaster.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSENegative. 1M: -3.62%, 3M: -4.16%, 6M: -5.72%Cheap relative to sector P/E, but justified given poor fundamentals.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Cell Point announced the resignation of a director on April 3, 2026. Trading volume exceeded the daily average by 23.08% on March 23, 2026. The share price increased by over 6.43% to on March 20, 2026.

CORE STORY (THE REAL GAME)

Why Now
  • Specialty retail sector growth
  • Low valuation relative to sector
  • Potential turnaround story
Potential Catalysts
  • Significant order wins
  • Improved quarterly results
  • Successful expansion into new markets
Key Risks
  • Micro-cap illiquidity
  • High debt-to-equity ratio
  • Negative free cash flow
  • Low ROE
Institutional Activity

Promoter holding steady at 73.06%. No FII/DII interest.

Macro Context

Indian retail sector is projected to grow to $2.5 trillion by 2035.

Cash Flow Quality

No. Free Cash Flow 5Y: ₹-23.68 Cr

3–6 Month Outlook

If Cell Point can improve its financial performance and capitalize on the growing specialty retail market, it could see significant upside. However, the risks are substantial, and investors should proceed with caution.

Primary Thesis Risk

Inability to service debt will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

0.51%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

4.77%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

3.81%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Cell Point India Ltd Valuation Check

Average

Price to Earnings (P/E)

38.48x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

39.01x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

73.06%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-13.64%

Net profit growth vs same quarter last year

Average

Revenue Growth (Quarterly YoY)

15.26%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

2.74%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-57.37%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-25.39%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.90x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.07x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-23.68 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Cell Point India Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CELLPOINT across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Strong Revenue Growth (15.26%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Balanced Promoter Holding (73.06%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.51%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (4.77%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (3.81%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Profit Decline Concern (-13.64%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (2.74% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-57.37% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-25.39% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Weak Interest Coverage (1.07x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-23.68 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Cell Point India Ltd vs Speciality Retail Peers

Peer Comparison - Speciality Retail

Compare Cell Point India Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
19.6/100
15
₹32.32
38.5
Average
0.51%
Poor
4.77%
Poor
0.9
Good
-25.39%
Poor
2.74%
Average
0.00%
Trent Ltd...
TRENT500251
60.6/100
4157
₹149854.09
92.4
Average
30.40%
Excellent
30.71%
Excellent
0.4
Excellent
67.15%
Excellent
37.50%
Excellent
0.12%
7/100
99
₹15826.24
145.6
Average
2.7
Poor
0.00%
45.2/100
399
₹15037.41
39.0
Average
22.26%
Excellent
25.93%
Excellent
0.3
Excellent
9.41%
Good
8.66%
Good
1.29%
17.2/100
63
₹9356.18
-10.93%
Poor
-2.87%
Poor
0.9
Good
-3.51%
Poor
0.00%
65/100
244
₹9061.65
91.0
Average
23.28%
Excellent
16.87%
Good
3.4
Poor
84.15%
Excellent
21.86%
Excellent
0.00%
53.1/100
522
₹6857.85
63.5
Average
20.26%
Excellent
19.13%
Good
0.7
Good
50.55%
Excellent
23.18%
Excellent
0.21%
22.9/100
466
₹6713.37
-3.63%
Poor
16.93%
Good
1.2
Average
13.81%
Good
5.04%
Good
0.32%
39.5/100
2295
₹3196.17
1737.0
Average
1.48%
Poor
1.66%
Poor
0.0
Excellent
68.04%
Excellent
-2.81%
Poor
0.00%
31.4/100
325
₹2739.59
31.0
Average
14.32%
Average
15.09%
Good
0.7
Good
12.08%
Good
16.69%
Excellent
0.00%
55.1/100
106
₹2456.80
18.9
Average
7.78%
Poor
12.37%
Average
0.3
Excellent
15.17%
Excellent
4.46%
Average
0.62%

Cell Point India Ltd Quarterly Performance

Latest quarterly metrics for CELLPOINT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

15.26%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-13.64%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

2.74%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-25.39%

Compounded annual net profit growth over 5 years

Cell Point India Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CELLPOINT — calculated from daily price history

59RSI 14
Neutral — RSI 59

Momentum is balanced — neither overbought nor oversold.

SMA 50
16
▼ Price below SMA 50 — Short-term bearish
SMA 200
18
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
6K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Cell Point India Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Cell Point India Ltd (CELLPOINT) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Cell Point India Ltd

About CELLPOINT (Cell Point India Ltd)

Cell Point India Ltd (CELLPOINT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Speciality Retail sector with ...a current market capitalisation of ₹32.32 (Cr). Cell Point India Ltd has delivered a Return on Equity (ROE) of 0.51% and a ROCE of 4.77%. The debt-to-equity ratio stands at 0.90, reflecting the company's capital structure. Investors tracking CELLPOINT share price can monitor key metrics including P/E ratio, promoter holding of 73.06%, and quarterly earnings growth.

Company Details

Symbol:CELLPOINT
Industry:Speciality Retail
Sector:Speciality Retail
Website:N/A

CELLPOINT Share Price: Frequently Asked Questions

What is the current share price of Cell Point India Ltd?

Cell Point India Ltd (CELLPOINT) trades at ₹15.35 on NSE. Market cap ₹32.32 (Cr). Educational data only.

What is the P/E ratio of Cell Point India Ltd?

Cell Point India Ltd has a P/E of 38.48x vs industry average 39.01x.

What is the Bull Run score for Cell Point India Ltd?

Cell Point India Ltd has a Bull Run score of 19.6/100 based on 25+ financial parameters.

Does Cell Point India Ltd pay dividends?

Cell Point India Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Cell Point India Ltd?

Cell Point India Ltd has ROE of 0.51%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Cell Point India Ltd?

Cell Point India Ltd has debt-to-equity of 0.90.

Is Cell Point India Ltd a good investment?

Bull Run gives Cell Point India Ltd a score of 19.6/100. This is not investment advice — consult a SEBI-registered advisor.